0001945638-24-000001.txt : 20240904 0001945638-24-000001.hdr.sgml : 20240904 20240904125049 ACCESSION NUMBER: 0001945638-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240904 EFFECTIVENESS DATE: 20240904 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arsenal Biosciences, Inc. CENTRAL INDEX KEY: 0001945638 ORGANIZATION NAME: IRS NUMBER: 824296120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-523129 FILM NUMBER: 241276576 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 240-8844 MAIL ADDRESS: STREET 1: 2 TOWER PLACE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001945638 Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 (650) 240-8844 DELAWARE None None Corporation true Kenneth Drazan c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Executive Officer Director James Ahlers c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Executive Officer Irene Pleasure c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Executive Officer Valentin Barsan c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Director Sean Parker c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Director Matthew Fust c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Director Brook Byers c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Director Beth Seidenberg c/o Arsenal Biosciences, Inc. 329 Oyster Point Blvd South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2024-07-09 false true false 0 325352578 325352578 0 Series C Preferred Stock and the respective common stock issuable upon conversion thereof. false 26 0 0 0 false Arsenal Biosciences, Inc. /s/Irene Pleasure Irene Pleasure Secretary 2024-09-04